These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34997317)
1. SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling. Zhang W; Yang S; Chen D; Yuwen D; Zhang J; Wei X; Han X; Guan X Cell Mol Life Sci; 2022 Jan; 79(1):59. PubMed ID: 34997317 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169 [TBL] [Abstract][Full Text] [Related]
4. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Qiao Y; Wang B; Yan Y; Niu L Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485 [TBL] [Abstract][Full Text] [Related]
6. LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA. Tang J; Zhong G; Zhang H; Yu B; Wei F; Luo L; Kang Y; Wu J; Jiang J; Li Y; Wu S; Jia Y; Liang X; Bi A Cell Death Dis; 2018 Dec; 9(12):1167. PubMed ID: 30518934 [TBL] [Abstract][Full Text] [Related]
7. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis. Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis. Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718 [TBL] [Abstract][Full Text] [Related]
9. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
10. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
11. Endothelial cells promote triple-negative breast cancer cell metastasis Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878 [TBL] [Abstract][Full Text] [Related]
12. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer. Ding L; Xie Z Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276 [TBL] [Abstract][Full Text] [Related]
13. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p. Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047 [TBL] [Abstract][Full Text] [Related]
14. Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review. Mehrtabar E; Khalaji A; Pandeh M; Farhoudian A; Shafiee N; Shafiee A; Ojaghlou F; Mahdavi P; Soleymani-Goloujeh M Med Oncol; 2024 Aug; 41(9):222. PubMed ID: 39120634 [TBL] [Abstract][Full Text] [Related]
15. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652 [TBL] [Abstract][Full Text] [Related]
16. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling. Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855 [TBL] [Abstract][Full Text] [Related]
17. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702. Mou E; Wang H Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203 [TBL] [Abstract][Full Text] [Related]
19. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320 [TBL] [Abstract][Full Text] [Related]
20. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]